NEWS & VIEWS

Global private equity and venture capital news and research

Posts Tagged ‘Venture Investors’

23 April 2014

OrbiMed leads $22m round for Aerpio Therapeutics

biotech_lrg Biopharmaceutical startup Aerpio Therapeutics has secured $22m in a round led by venture capital firm OrbiMed.

2 April 2014

Pfizer Ventures, student-run Wolverine Venture Fund back $21m NeuMoDx Series B

wolverine-hugh-jackman-angel-investor Pfizer Ventures has led a $21m Series B round for diagnostics business NeuMoDx, which also included backing from the student-managed Wolverine Venture Fund.

9 May 2013

Takeda acquires venture capital-backed biotech business Inviragen

Venture capital-backed biotech company Inviragen has agreed to a takeover offer of up to $250m from Japanese group Takeda Pharmaceutical Company.

5 April 2013

NetSocket ties up $9.2m Venture Investors-led financing round

Venture Investors has led a $9.2m Series B financing round for network services provider NetSocket.

30 August 2012

US biopharma Aerpio Therapeutics clinches $27m Series A

blood_vein_170sq Clinical‐stage biopharmaceutical company Aerpio Therapeutics has closed a $27m Series A financing led by life sciences investor Novartis BioVentures and joined by Venture Investors, Triathlon Medical Ventures, Kearny Venture Partners, Athenian Venture Partners and AgeChem Venture Fund.


Legals & Terms of UsePrivacy Policy


AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: Zetland House, 5-25 Scrutton St, London EC2A 4HJ
Content is © AltAssets 2000-2014